SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Changes

21 Jan 2005 14:25

Porvair PLC21 January 2005 For immediate release 21 January 2005 Porvair plc Appointments and resignation of non-Executive Directors The Board of Porvair plc ("Porvair") are pleased to announce the appointment ofCharles Matthews and Andrew Walker as non-Executive Directors with effect from24 January 2005, Michael Ost has indicated his wish to retire and will resignfrom the Board on the same date. Charles Matthews, 51, is Founder and Chairman of Sigma QC limited. He is anon-Executive Director of FKI plc and Chairman of Axeon Ltd and CreativeLearning Media Ltd. He was previously Chief Executive of Cosworth Engineeringand was a member of the Vickers plc Group Executive Board. Andrew Walker, 52, is a non-Executive Director of API Group plc, ManganeseBronze Holdings Limited, Halma plc and Ultra Electronics Holdings plc. He waspreviously Group Chief Executive of McKechnie plc and prior to that was GroupChief Executive of South Wales Electricity plc. He was previously anon-Executive Director of Galileo Innovation Plc. Charles Mathews and Andrew Walker will both join the Audit Committee,Remuneration Committee and Nominations Committee of Porvair. The Group confirms that there are no further matters to be disclosed pursuant tothe requirements of paragraph 16.4 of the listing rules. Chairman, John Morgan, said: "I am delighted that Charles Mathews and Andrew Walker are joining our Board,both have had distinguished and broad ranging careers and will bring a wealth ofexperience to Porvair. Michael Ost has made a considerable contribution toPorvair over the last six years and has been a very valuable member of theBoard. We wish him a long and happy retirement." For further information please contact: Porvair plcBen Stocks, Chief Executive 01553 765 500Chris Tyler, Group Finance Director Buchanan Communications 0207 466 5000Charles Ryland / Ben Willey Notes to Editors About Porvair Porvair is a group of specialist filtration and advanced materials businesses.Its products are used in a range of niche filtration markets, and are derivedfrom its expertise in the development and manufacture of porous and microporousceramics, metals, plastics and carbons. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.